Intrinsic Value of S&P & Nasdaq Contact Us

Phreesia, Inc. PHR NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
$544.71
+6233.8%
Analyst Price Target
$27.50
+219.8%

Phreesia, Inc. (PHR) has a consensus analyst rating of Buy, based on 25 analysts covering the stock. Of those, 20 recommend buying, 5 recommend holding, and 0 recommend selling.

The analyst consensus price target for PHR is $27.50, representing a +219.8% upside from the current price of $8.6. Price targets range from a low of $22.00 to a high of $33.00.

Analyst Consensus — PHR

Buy
Strong Buy
0
Buy
20
Hold
5
Sell
0
Strong Sell
0
25 analysts
Price Targets
Consensus$27.50
High$33.00
Low$22.00
Median$27.50
Last Month Avg-
Last Quarter Avg$26.50
Last Year Avg$30.12
All-Time Count38
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message